{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:59:01Z","timestamp":1791410341602,"version":"4.3.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2021-12372019"],"award-info":[{"award-number":["GR-2021-12372019"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-MAD-2022-12376035"],"award-info":[{"award-number":["PNRR-MAD-2022-12376035"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5M-2018-23680266"],"award-info":[{"award-number":["5M-2018-23680266"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC"],"award-info":[{"award-number":["RC"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In recent years, the seed amplification assay (SAA) has enabled the identification of pathological TDP-43 in the cerebrospinal fluid (CSF) and olfactory mucosa (OM) of patients with genetic forms of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Here, we investigated the seeding activity of TDP-43 in OM samples collected from patients with sporadic ALS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>OM samples were collected from patients with (a) sporadic motor neuron diseases (MND), including spinal ALS (<jats:italic>n<\/jats:italic>\u2009= 35), bulbar ALS (<jats:italic>n<\/jats:italic>\u2009= 18), primary lateral sclerosis (<jats:italic>n<\/jats:italic>\u2009= 10), and facial onset sensory and motor neuronopathy (<jats:italic>n<\/jats:italic>\u2009= 2); (b) genetic MND, including carriers of <jats:italic>C9orf72<\/jats:italic>\n              <jats:sup>\n                <jats:italic>exp<\/jats:italic>\n              <\/jats:sup> (<jats:italic>n<\/jats:italic>\u2009= 6), <jats:italic>TARDBP<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 4), <jats:italic>SQSTM1<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 3), <jats:italic>C9orf72<\/jats:italic>\n              <jats:sup>\n                <jats:italic>exp<\/jats:italic>\n              <\/jats:sup>\u2009+ <jats:italic>SQSTM1<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 1), <jats:italic>OPTN<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 1), <jats:italic>GLE1<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 1), <jats:italic>FUS<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 1) and <jats:italic>SOD1<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009= 4) mutations; (c) other neurodegenerative disorders (OND), including Alzheimer\u2019s disease (<jats:italic>n<\/jats:italic>\u2009= 3), dementia with Lewy bodies (<jats:italic>n<\/jats:italic>\u2009= 8) and multiple system atrophy (<jats:italic>n<\/jats:italic>\u2009= 6); and (d) control subjects (<jats:italic>n<\/jats:italic>\u2009= 22). All samples were subjected to SAA analysis for TDP-43 (TDP-43_SAA). Plasmatic levels of TDP-43 and neurofilament-light chain (NfL) were also assessed in a selected number of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>TDP-43_SAA was positive in 29\/65 patients with sporadic MND, 9\/21 patients with genetic MND, 6\/17 OND patients and 3\/22 controls. Surprisingly, one presymptomatic individual also tested positive. As expected, OM of genetic non-TDP-43-related MND tested negative. Interestingly, fluorescence values from non-MND samples that tested positive were consistently and significantly lower than those obtained with sporadic and genetic MND. Furthermore, among TDP-43-positive samples, the lag phase observed in MND patients was significantly longer than that in non-MND patients. Plasma TDP-43 levels were significantly higher in sporadic MND patients compared to controls and decreased as the disease progressed. Similarly, plasma NfL levels were higher in both sporadic and genetic MND patients and positively correlated with disease progression rate (\u0394FS). No significant correlations were detected between TDP-43_SAA findings and the biological, clinical, or neuropsychological parameters considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The OM of a subset of patients with sporadic MND can trigger seeding activity for TDP-43, as previously observed in genetic MND. Thus, TDP-43_SAA analysis of OM can improve the clinical characterization of ALS across different phenotypes and enhance our understanding of these diseases. Finally, plasma TDP-43 could serve as a potential biomarker for monitoring disease progression. However, further research is needed to confirm and expand these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13024-025-00833-0","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T16:29:48Z","timestamp":1745684988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Maria","family":"Vizziello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria Linda","family":"Dellarole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Ciullini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pascuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Bellandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Celauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Battipaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ciusani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Devigili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Adriana","family":"Della Seta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Margiotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Consonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Faltracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Tiraboschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Maria Silvia","family":"Portaleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zanusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Legname","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Dalla Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-9880","authenticated-orcid":false,"given":"Fabio","family":"Moda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"10","key":"833_CR1","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/jnnp.2011.244939","volume":"82","author":"MHB Huisman","year":"2011","unstructured":"Huisman MHB, de Jong SW, van Doormaal PTC, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82(10):1165\u201370. https:\/\/doi.org\/10.1136\/jnnp.2011.244939.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5\u20136","key":"833_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5\u20136):310\u201323. https:\/\/doi.org\/10.3109\/17482960802566824.","journal-title":"Amyotroph Lateral Scler"},{"issue":"22","key":"833_CR3","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1212\/WNL.0b013e3181a8269b","volume":"72","author":"PH Gordon","year":"2009","unstructured":"Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron\u2013dominant ALS, and typical ALS. Neurology. 2009;72(22):1948\u201352. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a8269b.","journal-title":"Neurology"},{"issue":"5","key":"833_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1212\/01.wnl.0000200962.94777.71","volume":"66","author":"PH Gordon","year":"2006","unstructured":"Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66(5):647\u201353. https:\/\/doi.org\/10.1212\/01.wnl.0000200962.94777.71.","journal-title":"Neurology"},{"issue":"11","key":"833_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(11):661\u201370. https:\/\/doi.org\/10.1038\/nrneurol.2014.184.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"833_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1212\/CPJ.0000000000000834","volume":"11","author":"EMJ de Boer","year":"2021","unstructured":"de Boer EMJ, Barritt AW, Elamin M, et al. Facial Onset Sensory and Motor Neuronopathy. Neurol Clin Pract. 2021;11(2):147\u201357. https:\/\/doi.org\/10.1212\/CPJ.0000000000000834.","journal-title":"Neurol Clin Pract"},{"issue":"3\u20134","key":"833_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. 2017;18(3\u20134):153\u201374. https:\/\/doi.org\/10.1080\/21678421.2016.1267768.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"1","key":"833_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neurol.2015.11.002","volume":"172","author":"P Couratier","year":"2016","unstructured":"Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev Neurol (Paris). 2016;172(1):37\u201345. https:\/\/doi.org\/10.1016\/j.neurol.2015.11.002.","journal-title":"Rev Neurol (Paris)"},{"issue":"7","key":"833_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","volume":"82","author":"A Chio","year":"2011","unstructured":"Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(7):740\u20136. https:\/\/doi.org\/10.1136\/jnnp.2010.235952.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"833_CR10","doi-asserted-by":"publisher","unstructured":"Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80- ). Published online 2006. https:\/\/doi.org\/10.1126\/science.1134108","DOI":"10.1126\/science.1134108"},{"issue":"6","key":"833_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41593-023-01341-4","volume":"26","author":"ST Kumar","year":"2023","unstructured":"Kumar ST, Nazarov S, Porta S, et al. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nat Neurosci. 2023;26(6):983\u201396. https:\/\/doi.org\/10.1038\/s41593-023-01341-4.","journal-title":"Nat Neurosci"},{"issue":"1","key":"833_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/neup.12606","volume":"40","author":"T Takeda","year":"2020","unstructured":"Takeda T, Kitagawa K, Arai K. Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology. 2020;40(1):40\u201356. https:\/\/doi.org\/10.1111\/neup.12606.","journal-title":"Neuropathology"},{"key":"833_CR13","doi-asserted-by":"publisher","unstructured":"Neumann M, Lee EB, Mackenzie IR. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance. In: ; 2021:201\u2013217. https:\/\/doi.org\/10.1007\/978-3-030-51140-1_13","DOI":"10.1007\/978-3-030-51140-1_13"},{"issue":"8","key":"833_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnen\/nlx049","volume":"76","author":"T Mishima","year":"2017","unstructured":"Mishima T, Koga S, Lin WL, et al. Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy. J Neuropathol Exp Neurol. 2017;76(8):676\u201382. https:\/\/doi.org\/10.1093\/jnen\/nlx049.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"833_CR15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327. https:\/\/doi.org\/10.1093\/brain\/awz099.","journal-title":"Brain"},{"issue":"10","key":"833_CR16","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl CC, Temiz P, Miller SE, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008;79(10):1186\u20139. https:\/\/doi.org\/10.1136\/jnnp.2007.131334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"833_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N. TDP-43 Pathology in Alzheimer\u2019s Disease. Mol Neurodegener. 2021;16(1):84. https:\/\/doi.org\/10.1186\/s13024-021-00503-x.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"833_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007;114(3):221\u20139. https:\/\/doi.org\/10.1007\/s00401-007-0261-2.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"833_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bpa.12424","volume":"27","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J. TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing. Brain Pathol. 2017;27(4):472\u20139. https:\/\/doi.org\/10.1111\/bpa.12424.","journal-title":"Brain Pathol"},{"issue":"7","key":"833_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/nan.12485","volume":"44","author":"S Koga","year":"2018","unstructured":"Koga S, Lin WL, Walton RL, Ross OA, Dickson DW. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and \u03b1-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol. 2018;44(7):707\u201321. https:\/\/doi.org\/10.1111\/nan.12485.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"833_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu K, Nakashima-Yasuda H, Forman MS, et al. Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies. J Neuropathol Exp Neurol. 2008;67(6):555\u201364. https:\/\/doi.org\/10.1097\/NEN.0b013e31817713b5.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"833_CR22","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1093\/brain\/awac091","volume":"145","author":"Y Riku","year":"2022","unstructured":"Riku Y, Iwasaki Y, Ishigaki S, et al. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration. Brain. 2022;145(8):2769\u201384. https:\/\/doi.org\/10.1093\/brain\/awac091.","journal-title":"Brain"},{"issue":"12","key":"833_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease. J Neuropathol Exp Neurol. 2008;67(12):1159\u201365. https:\/\/doi.org\/10.1097\/NEN.0b013e31818e8951.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"833_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.31083\/j.fbl2810255","volume":"28","author":"F Moda","year":"2023","unstructured":"Moda F, Ciullini A, Dellarole IL, et al. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception. Front Biosci. 2023;28(10):255. https:\/\/doi.org\/10.31083\/j.fbl2810255.","journal-title":"Front Biosci"},{"issue":"1","key":"833_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0888-7543(03)00214-3","volume":"83","author":"HY Wang","year":"2004","unstructured":"Wang HY, Wang IF, Bose J, Shen CKJ. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics. 2004;83(1):130\u20139. https:\/\/doi.org\/10.1016\/S0888-7543(03)00214-3.","journal-title":"Genomics"},{"key":"833_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.07.033","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in als and FTD: Disrupted RNA and protein homeostasis. Neuron Published online. 2013. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033.","journal-title":"Neuron Published online"},{"issue":"22","key":"833_CR27","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1242\/jcs.038950","volume":"121","author":"YM Ayala","year":"2008","unstructured":"Ayala YM, Zago P, D\u2019Ambrogio A, et al. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci. 2008;121(22):3778\u201385. https:\/\/doi.org\/10.1242\/jcs.038950.","journal-title":"J Cell Sci"},{"issue":"3","key":"833_CR28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602\u201311. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"833_CR29","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/ncomms6845","volume":"6","author":"TJ Cohen","year":"2015","unstructured":"Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VMY. An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun. 2015;6(1):5845. https:\/\/doi.org\/10.1038\/ncomms6845.","journal-title":"Nat Commun"},{"issue":"20","key":"833_CR30","doi-asserted-by":"publisher","first-page":"12508","DOI":"10.3390\/ijms232012508","volume":"23","author":"Y Tamaki","year":"2022","unstructured":"Tamaki Y, Urushitani M. Molecular Dissection of TDP-43 as a Leading Cause of ALS\/FTLD. Int J Mol Sci. 2022;23(20):12508. https:\/\/doi.org\/10.3390\/ijms232012508.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"833_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","volume":"173","author":"LM Igaz","year":"2008","unstructured":"Igaz LM, Kwong LK, Xu Y, et al. Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Am J Pathol. 2008;173(1):182\u201394. https:\/\/doi.org\/10.2353\/ajpath.2008.080003.","journal-title":"Am J Pathol"},{"issue":"11","key":"833_CR32","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain. 2012;135(11):3380\u201391. https:\/\/doi.org\/10.1093\/brain\/aws230.","journal-title":"Brain"},{"issue":"1","key":"833_CR33","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta S, Xu Y, Restrepo CR, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9(1):4220. https:\/\/doi.org\/10.1038\/s41467-018-06548-9.","journal-title":"Nat Commun"},{"issue":"5","key":"833_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","volume":"138","author":"I Kawakami","year":"2019","unstructured":"Kawakami I, Arai T, Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol. 2019;138(5):751\u201370. https:\/\/doi.org\/10.1007\/s00401-019-02077-x.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"833_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/nan.12732","volume":"47","author":"S Porta","year":"2021","unstructured":"Porta S, Xu Y, Lehr T, et al. Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo. Neuropathol Appl Neurobiol. 2021;47(7):1033\u201349. https:\/\/doi.org\/10.1111\/nan.12732.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"833_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00401-020-02201-2","volume":"142","author":"HHC Lau","year":"2021","unstructured":"Lau HHC, Ingelsson M, Watts JC. The existence of A\u03b2 strains and their potential for driving phenotypic heterogeneity in Alzheimer\u2019s disease. Acta Neuropathol. 2021;142(1):17\u201339. https:\/\/doi.org\/10.1007\/s00401-020-02201-2.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"833_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41583-022-00603-7","volume":"23","author":"D Li","year":"2022","unstructured":"Li D, Liu C. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases. Nat Rev Neurosci. 2022;23(9):523\u201334. https:\/\/doi.org\/10.1038\/s41583-022-00603-7.","journal-title":"Nat Rev Neurosci"},{"issue":"7880","key":"833_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/d41586-021-02611-6","volume":"598","author":"H Stahlberg","year":"2021","unstructured":"Stahlberg H, Riek R. Structural strains of misfolded tau protein define different diseases. Nature. 2021;598(7880):264\u20135. https:\/\/doi.org\/10.1038\/d41586-021-02611-6.","journal-title":"Nature"},{"issue":"1","key":"833_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41467-019-13787-x","volume":"11","author":"Z He","year":"2020","unstructured":"He Z, McBride JD, Xu H, et al. Transmission of tauopathy strains is independent of their isoform composition. Nat Commun. 2020;11(1):7. https:\/\/doi.org\/10.1038\/s41467-019-13787-x.","journal-title":"Nat Commun"},{"issue":"1","key":"833_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau A, So RWL, Lau HHC, et al. \u03b1-Synuclein strains target distinct brain regions and cell types. Nat Neurosci. 2020;23(1):21\u201331. https:\/\/doi.org\/10.1038\/s41593-019-0541-x.","journal-title":"Nat Neurosci"},{"issue":"12","key":"833_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168011","volume":"435","author":"RWL So","year":"2023","unstructured":"So RWL, Watts JC. \u03b1-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases. J Mol Biol. 2023;435(12): 168011. https:\/\/doi.org\/10.1016\/j.jmb.2023.168011.","journal-title":"J Mol Biol"},{"key":"833_CR42","doi-asserted-by":"publisher","unstructured":"Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. In: Handbook of Clinical Neurology. ; 2016:225\u2013238. https:\/\/doi.org\/10.1016\/B978-0-12-802973-2.00013-6","DOI":"10.1016\/B978-0-12-802973-2.00013-6"},{"issue":"1","key":"833_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2021","unstructured":"de Boer EMJ, Orie VK, Williams T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2021;92(1):86\u201395. https:\/\/doi.org\/10.1136\/jnnp-2020-322983.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"833_CR44","doi-asserted-by":"publisher","unstructured":"Aditi, Glass L, Dawson TR, Wente SR. An amyotrophic lateral sclerosis-linked mutation in GLE1 alters the cellular pool of human Gle1 functional isoforms. Adv Biol Regul. 2016;62:25\u201336. https:\/\/doi.org\/10.1016\/j.jbior.2015.11.001","DOI":"10.1016\/j.jbior.2015.11.001"},{"key":"833_CR45","doi-asserted-by":"publisher","unstructured":"Kwiatkowski TJ, Bosco DA, LeClerc AL, et al. Mutations in the FUS\/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science (80- ). 2009;323(5918):1205\u20131208. https:\/\/doi.org\/10.1126\/science.1166066","DOI":"10.1126\/science.1166066"},{"issue":"5","key":"833_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IRA Mackenzie","year":"2007","unstructured":"Mackenzie IRA, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427\u201334. https:\/\/doi.org\/10.1002\/ana.21147.","journal-title":"Ann Neurol"},{"issue":"2","key":"833_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2007.03.066","volume":"420","author":"J Robertson","year":"2007","unstructured":"Robertson J, Sanelli T, Xiao S, et al. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett. 2007;420(2):128\u201332. https:\/\/doi.org\/10.1016\/j.neulet.2007.03.066.","journal-title":"Neurosci Lett"},{"issue":"2","key":"833_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24672","volume":"10","author":"S Matsuura","year":"2024","unstructured":"Matsuura S, Tatebe H, Higuchi M, Tokuda T. Validation of a newly developed immunoassay for TDP-43 in human plasma. Heliyon. 2024;10(2): e24672. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24672.","journal-title":"Heliyon"},{"issue":"1","key":"833_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13195-022-01091-8","volume":"14","author":"K Katisko","year":"2022","unstructured":"Katisko K, Huber N, Kokkola T, et al. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype. Alzheimers Res Ther. 2022;14(1):151. https:\/\/doi.org\/10.1186\/s13195-022-01091-8.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"833_CR50","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, \u00d6zdemir S, Fritz C, et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med. 2024;30(6):1771\u201383. https:\/\/doi.org\/10.1038\/s41591-024-02937-4.","journal-title":"Nat Med"},{"issue":"6","key":"833_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/NEN.0000000000000198","volume":"74","author":"T Takeda","year":"2015","unstructured":"Takeda T, Iijima M, Uchihara T, et al. TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol. 2015;74(6):547\u201356. https:\/\/doi.org\/10.1097\/NEN.0000000000000198.","journal-title":"J Neuropathol Exp Neurol"},{"key":"833_CR52","doi-asserted-by":"publisher","unstructured":"Cazzaniga FA, De Luca CMG, Bistaffa E, et al. Cell-free amplification of prions: Where do we stand? In: Progress in Molecular Biology and Translational Science. ; 2020:325\u2013358. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.005","DOI":"10.1016\/bs.pmbts.2020.08.005"},{"key":"833_CR53","doi-asserted-by":"publisher","unstructured":"Dellarole IL, Vacchi E, Ruiz-Barrio I, et al. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies. npj Park Dis. 2024;10(1):1\u201312. https:\/\/doi.org\/10.1038\/s41531-024-00728-9","DOI":"10.1038\/s41531-024-00728-9"},{"key":"833_CR54","doi-asserted-by":"publisher","unstructured":"Fontana E, Bongianni M, Benussi A, et al. Detection of TDP\u201043 seeding activity in the olfactory mucosa from patients with frontotemporal dementia. Alzheimer\u2019s Dement. Published online October 31, 2023. https:\/\/doi.org\/10.1002\/alz.13541","DOI":"10.1002\/alz.13541"},{"key":"833_CR55","doi-asserted-by":"publisher","unstructured":"Scial\u00f2 C, Tran TH, Salzano G, et al. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun. 2020;2(2). https:\/\/doi.org\/10.1093\/braincomms\/fcaa142","DOI":"10.1093\/braincomms\/fcaa142"},{"key":"833_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/146608200300079536","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Published online. 2000. https:\/\/doi.org\/10.1080\/146608200300079536.","journal-title":"Amyotroph Lateral Scler Published online"},{"issue":"1\u20132","key":"833_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1\u20132):13\u201321. https:\/\/doi.org\/10.1016\/S0022-510X(99)00210-5.","journal-title":"J Neurol Sci"},{"issue":"2","key":"833_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a.","journal-title":"Neurology"},{"issue":"3","key":"833_CR59","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awr351","volume":"135","author":"JC Roche","year":"2012","unstructured":"Roche JC, Rojas-Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135(3):847\u201352. https:\/\/doi.org\/10.1093\/brain\/awr351.","journal-title":"Brain"},{"issue":"7\u20138","key":"833_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/21678421.2016.1183679","volume":"17","author":"B Poletti","year":"2016","unstructured":"Poletti B, Solca F, Carelli L, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Front Degener. 2016;17(7\u20138):489\u201398. https:\/\/doi.org\/10.1080\/21678421.2016.1183679.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"6","key":"833_CR61","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10072-017-2919-4","volume":"38","author":"M Siciliano","year":"2017","unstructured":"Siciliano M, Trojano L, Trojsi F, et al. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores. Neurol Sci. 2017;38(6):1059\u201368. https:\/\/doi.org\/10.1007\/s10072-017-2919-4.","journal-title":"Neurol Sci"},{"issue":"6","key":"833_CR62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WCO.0000000000000488","volume":"30","author":"MJ Strong","year":"2017","unstructured":"Strong MJ. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr Opin Neurol. 2017;30(6):599\u2013607. https:\/\/doi.org\/10.1097\/WCO.0000000000000488.","journal-title":"Curr Opin Neurol"},{"key":"833_CR63","doi-asserted-by":"publisher","unstructured":"Dalla Bella E, Bersano E, Bruzzone MG, et al. Behavioral and Cognitive Phenotypes of Patients With Amyotrophic Lateral Sclerosis Carrying SOD1 Variants. Neurology. 2022;99(18). https:\/\/doi.org\/10.1212\/WNL.0000000000201044","DOI":"10.1212\/WNL.0000000000201044"},{"issue":"1","key":"833_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca CMG, Elia AE, Portaleone SM, et al. Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl Neurodegener. 2019;8(1):24. https:\/\/doi.org\/10.1186\/s40035-019-0164-x.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"833_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00491-y","volume":"16","author":"C Bargar","year":"2021","unstructured":"Bargar C, De Luca CMG, Devigili G, et al. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories. Mol Neurodegener. 2021;16(1):1\u201319. https:\/\/doi.org\/10.1186\/s13024-021-00491-y.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"833_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1109\/87.974338","volume":"10","author":"RK Pearson","year":"2002","unstructured":"Pearson RK. Outliers in process modeling and identification. IEEE Trans Control Syst Technol. 2002;10(1):55\u201363. https:\/\/doi.org\/10.1109\/87.974338.","journal-title":"IEEE Trans Control Syst Technol"},{"key":"833_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2024.108335","volume":"72","author":"J Wang","year":"2024","unstructured":"Wang J, Guo X. The Gompertz model and its applications in microbial growth and bioproduction kinetics: Past, present and future. Biotechnol Adv. 2024;72: 108335. https:\/\/doi.org\/10.1016\/j.biotechadv.2024.108335.","journal-title":"Biotechnol Adv"},{"issue":"4","key":"833_CR68","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate. Ann Intern Med. 2006;145(4):247\u201354. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00004.","journal-title":"Ann Intern Med"},{"issue":"15","key":"833_CR69","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1212\/WNL.0b013e3181bbff05","volume":"73","author":"N Ticozzi","year":"2009","unstructured":"Ticozzi N, Silani V, LeClerc AL, et al. Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology. 2009;73(15):1180\u20135. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bbff05.","journal-title":"Neurology"},{"key":"833_CR70","doi-asserted-by":"publisher","unstructured":"Ren Y, Li S, Chen S, et al. TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis. Front Neurol. 2021;12. https:\/\/doi.org\/10.3389\/fneur.2021.663637","DOI":"10.3389\/fneur.2021.663637"},{"issue":"1\u20132","key":"833_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/21678421.2023.2285428","volume":"25","author":"EN Smith","year":"2024","unstructured":"Smith EN, Lee J, Prilutsky D, et al. Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank. Amyotroph Lateral Scler Front Degener. 2024;25(1\u20132):170\u20136. https:\/\/doi.org\/10.1080\/21678421.2023.2285428.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"4","key":"833_CR72","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/genes15040496","volume":"15","author":"P Shahim","year":"2024","unstructured":"Shahim P, Norato G, Sinaii N, et al. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Genes (Basel). 2024;15(4):496. https:\/\/doi.org\/10.3390\/genes15040496.","journal-title":"Genes (Basel)"},{"issue":"3","key":"833_CR73","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024463","volume":"8","author":"T Nonaka","year":"2018","unstructured":"Nonaka T, Hasegawa M. TDP-43 Prions. Cold Spring Harb Perspect Med. 2018;8(3): a024463. https:\/\/doi.org\/10.1101\/cshperspect.a024463.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"833_CR74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74(1):20\u201338. https:\/\/doi.org\/10.1002\/ana.23937.","journal-title":"Ann Neurol"},{"issue":"2","key":"833_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del TK, R\u00fcb U, de Vos RA, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"issue":"16","key":"833_CR76","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.3390\/ijms23169364","volume":"23","author":"B Roberts","year":"2022","unstructured":"Roberts B, Theunissen F, Mastaglia FL, Akkari PA, Flynn LL. Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics? Int J Mol Sci. 2022;23(16):9364. https:\/\/doi.org\/10.3390\/ijms23169364.","journal-title":"Int J Mol Sci"},{"key":"833_CR77","doi-asserted-by":"publisher","unstructured":"Smith R, Hovren H, Bowser R, et al. Misfolded <scp>alpha\u2010synuclein<\/scp> in amyotrophic lateral sclerosis: Implications for diagnosis and treatment. Eur J Neurol. 2024;31(4). https:\/\/doi.org\/10.1111\/ene.16206","DOI":"10.1111\/ene.16206"},{"key":"833_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.166953","author":"S Dhakal","year":"2021","unstructured":"Dhakal S, Wyant CE, George HE, Morgan SE, Rangachari V. Prion-like C-Terminal Domain of TDP-43 and \u03b1-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils. J Mol Biol Published online. 2021. https:\/\/doi.org\/10.1016\/j.jmb.2021.166953.","journal-title":"J Mol Biol Published online"},{"key":"833_CR79","doi-asserted-by":"publisher","unstructured":"Brozzetti L, Sacchetto L, Cecchini MP, et al. Neurodegeneration-Associated Proteins in Human Olfactory Neurons Collected by Nasal Brushing. Front Neurosci. 2020;14. https:\/\/doi.org\/10.3389\/fnins.2020.00145","DOI":"10.3389\/fnins.2020.00145"},{"key":"833_CR80","doi-asserted-by":"publisher","unstructured":"Verde F, Otto M, Silani V. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front Neurosci. 2021;15. https:\/\/doi.org\/10.3389\/fnins.2021.679199","DOI":"10.3389\/fnins.2021.679199"},{"key":"833_CR81","doi-asserted-by":"publisher","unstructured":"Verde F, Milone I, Colombo E, et al. Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis. Front Aging Neurosci. 2023;15. https:\/\/doi.org\/10.3389\/fnagi.2023.1132808","DOI":"10.3389\/fnagi.2023.1132808"},{"key":"833_CR82","doi-asserted-by":"publisher","unstructured":"Vacchiano V, Mastrangelo A, Zenesini C, et al. Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study. Front Aging Neurosci. 2021;13. https:\/\/doi.org\/10.3389\/fnagi.2021.753242","DOI":"10.3389\/fnagi.2021.753242"},{"key":"833_CR83","doi-asserted-by":"publisher","unstructured":"Steinacker P, Feneberg E, Weishaupt J, et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry. Published online August 21, 2015:jnnp-2015\u2013311387. https:\/\/doi.org\/10.1136\/jnnp-2015-311387","DOI":"10.1136\/jnnp-2015-311387"},{"issue":"5","key":"833_CR84","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L, et al. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2017;74(5):525. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5398.","journal-title":"JAMA Neurol"},{"issue":"6","key":"833_CR85","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00415-020-09761-z","volume":"267","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh S, Vacchiano V, Zenesini C, et al. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis. J Neurol. 2020;267(6):1699\u2013708. https:\/\/doi.org\/10.1007\/s00415-020-09761-z.","journal-title":"J Neurol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00833-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T16:29:49Z","timestamp":1745684989000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00833-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00833-0","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Comitato Etico Territoriale Lombardia 4 (CET 4) and performed in line with the principles of the Declaration of Helsinki. All subjects were included according to the study protocol and gave written informed consent to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}